SCHEMBL21230409

SCHEMBL21230409

C[C@@H]1C[C@H](CO)N(C)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15743726 1.00 — —
SCHEMBL6628886 1.00 — —
SCHEMBL20016966 1.00 — —
SCHEMBL31737638 1.00 — —
SCHEMBL16217602 0.79 — —
SCHEMBL16664447 0.79 GAA (0.33) —
SCHEMBL6630802 0.79 GAA (0.33) —
SCHEMBL22834149 0.79 — —
SCHEMBL24789390 0.78 — —
SCHEMBL14395729 0.78 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019150305-A1 SUBSTITUTED QUINAZOLINE AND PYRIDOPYRIMIDINE DERIVATIVES USEFUL AS ANTICANCER AGENTS PFIZER INC. (US) 2019-08-08 — — WO disclosed
Send feedback